Background: Despite recent advances in chronic kidney disease (CKD) and end-stage renal
disease (ESRD) management, morbidity and mortality in this population remain …

Chronic, low‐grade inflammation is a common comorbid condition in chronic kidney disease
(CKD), and particularly in chronic dialysis patients. In this review, we consider the question …

Despite marked improvements in renal replacement therapy during the last 30 years, the
age-adjusted mortality rate in end-stage renal disease (ESRD) patients is still unacceptably …

It has become apparent that inflammation and inflammatory reactions can evoke renal injury
and promote chronic kidney disease (CKD) progression. Under physiological condition …

Inflammation as a risk factor and target for therapy in chro... : Current Opinion in Nephrology and
Hypertension Inflammation as a risk factor and target for therapy in chronic kidney disease …

Chronic kidney disease (CKD) affects many adults worldwide. Persistent low-grade
inflammation is a substantial factor in its development and progression and has correlated …

Cardiovascular disease (CVD) remains the major cause of morbidity and mortality in chronic
kidney disease (CKD). As traditional risk factors cannot alone explain the unacceptable high …

Morbidity and mortality are markedly elevated in chronic kidney disease (CKD) patients as
consequence of cardiovascular risk factors clustering. Non-traditional risk factors such as …

Significance: Chronic kidney disease (CKD) can be regarded as a burden of lifestyle
disease that shares common underpinning features and risk factors with the aging process; …

Cardiovascular disease (CVD) remains the main cause of morbidity and mortality in patients
with end‐stage renal disease (ESRD). Although traditional risk factors are common in ESRD …